Special purpose needles are used in target specific drug deliveries or collection of samples such as fluid and cells from organs or lumps and are available in the market with various advanced features, shapes, and sizes. The global market for special purpose needles is showing a steady growth owing to an increasing geriatric population. In terms of revenue, the global special purpose needles market is projected to expand at a CAGR of 7.4% during the forecast period (2016–2026) and is expected to be valued at US$ 17,261.5 million by the end of 2026.
The global special purpose needles market can be segmented on the basis of product type (Fine Aspirating Needles, Biopsy Needles, Hypodermic Needles, Pen Needles, Suture Needles, IV Catheter Needles, Implantation Needles, Dental Needles, Ophthalmic Needles, Blood Collection Needles, Spinal Anaesthesia Needles, Epidural Needles, AV Fistula Needles, Cannula Needles); application (Sample Collection, Drug Delivery); and distribution channel (Hospital Pharmacies,Private Clinics, Retail Pharmacies and Drug Stores, E-Commerce). The Hypodermic Needles product type segment and the Drug Delivery application segment are projected to dominate the global special purpose needles market in terms of value. The Hospital Pharmacies distribution channel segment is expected to hold maximum share of the global special purpose needles market.
Key market dynamics
Increasing prevalence of diabetes and infectious diseases and increasing incidence of cancer and spine disorders across the globe are the primary factors driving the growth of the global special purpose needles market. Growing government regulations on the use of safety needles, increasing focus on advanced healthcare systems, joint efforts by supply chain executives to increase efficiency, and rising government support in developed economies is creating high potential growth opportunities for players operating in the global special purpose needles market. However, high costs associated with special purpose needles, an increasing awareness of needle-free injection technology, and product recalls due to low quality are some of the factors likely to impede growth of the special purpose needles market over the forecast period.
The global special purpose needles market is likely to witness some key trends in the next 10 years. There is an increasing collaboration between the government and private medical companies to raise awareness among patients regarding the unsafe use of reusable needles. Companies are also directing their efforts towards the production of user-friendly safety needles to prevent needle injuries that are the main cause of a rising prevalence of HIV and other blood borne diseases.
Regional market projections
The global special purpose needles market is segmented into seven main regions – North America, Latin America, Western Europe, Eastern Europe, APEJ, Japan, and Middle East & Africa (MEA). In terms of value, North America is expected to be the dominant regional market by the end of 2016 and is expected to reach a market valuation of US$ 5,506.7 Mn by the end of 2026, registering a CAGR of 8.2% over the forecast period. APEJ is expected to be the fastest growing market in terms of revenue growth in the global special purpose needles market, registering a CAGR of 7.7% over the forecast period. The APEJ market is anticipated to reach US$ 2,383.1 Mn by the end of 2026. The markets in North America, Western Europe, and APEJ are estimated to collectively hold 74.7% market share of the global special purpose needles market in 2016.
special purpose needles market_image for Preview Analysis
Leading market players
Medtronic, B. Braun Melsungen AG, Becton, Dickinson and Company, Terumo Corporation, Smiths Medical, Boston Scientific Corporation, Novo Nordisk A/S, Argon Medical Devices, Inc., Stryker Corporation, NIPRO Medical Corporation, Cook Medical, and SERAG-WIESSNER GmbH & Co. are some of the major players operating in the global special purpose needles market.
Our reports have been used by over 10K customers, including:
Transformational Health team provides critical insights into the Asian specialty generics market with this research service, highlighting growth opportunities, selected countries’ biopharmaceutical environment, and significant R&D, regulatory, and infrastructure reforms influencing its growth. The report examines similarities and contrasts...
145 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Nanotechnology in Drug Delivery Market to Reach $164.1 Billion by 2027
- Amid the COVID-19 crisis, the global market for Nanotechnology in Drug Delivery estimated at US$47.5 Billion in the year 2020, is projected to reach a revised size of US$164.1 Billion by 2027, growing at aCAGR of 19.4% over...
286 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Electronic Drug Delivery Systems Market to Reach $13.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for Electronic Drug Delivery Systems estimated at US$8.2 Billion in the year 2020, is projected to reach a revised size of US$13.8 Billion by 2027, growing at a CAGR of 7.6% over...
The major factors for the growth of the novel drug delivery systems (NDDS) market include the growing need of controlled release of drugs, advancement in pharmacology promoting increased adoption of novel drug delivery systems (NDDS), and technological advancements promoting the development of NDDS. There has been a remarkable increase...
307 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Intranasal Drug Delivery Market to Reach $59.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Intranasal Drug Delivery estimated at US$44.7 Billion in the year 2020, is projected to reach a revised size of US$59.2 Billion by 2027, growing at a CAGR of 4.1% over the analysis period...
Market Overview: The global chitosan market reached a value of US$ 2.49 Billion in 2020. Chitosan is a naturally occurring deacetylated chitin which is extracted from the hard outer-skeleton or shells of shrimps, crabs and lobsters, along with mushrooms and yeasts. It is primarily used as an ingredient in medicines...
588 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- The global market for Hydrogel is projected to reach US$15.3 billion by 2025, driven by their growing use in wound care products and drug delivery systems (DDS). Defined as a three-dimensional (3D) hydrophilic polymer capable of holding large amounts of water, hydrogel is valuable in biological applications...
112 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Novel Drug Delivery Systems (NDDS) Market to Reach $27.2 Billion by 2027
- Amid the COVID-19 crisis, the global market for Novel Drug Delivery Systems (NDDS) estimated at US$7.7 Billion in the year 2020, is projected to reach a revised size of US$27.2 Billion by 2027, growing at aCAGR of 19.7% over...
170 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Connected Drug Delivery Devices Market to Reach $1.5 Billion by 2027
- Amid the COVID-19 crisis, the global market for Connected Drug Delivery Devices estimated at US$166.9 Million in the year 2020, is projected to reach a revised size of US$1.5 Billion by 2027, growing at aCAGR of 36.4% over the...
294 pages •
By Global Industry Analysts
• Apr 2021
Abstract:
- Global Controlled Release Drug Delivery Market to Reach $57.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Controlled Release Drug Delivery estimated at US$36.7 Billion in the year 2020, is projected to reach a revised size of US$57.3 Billion by 2027, growing at a CAGR of 6.6% over...
Drug Delivery
World
China
United States
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.